Concepedia

Lydia Kriegl

LK

Statistics

Publications

21

Citations

1.8K

H-Index

18

Active since

2006

Affiliations

Ludwig-Maximilians-Universität München(Current)

Technical University of Munich

TUM Klinikum

Dana-Farber Cancer Institute

Institut Curie

Lydia Kriegl is an author at Ludwig-Maximilians-Universität München specializing in medicine, oncology, and molecular oncology.

Publications per year

2006–2013

21

Publications

21

CD133 expression is an independent prognostic marker for low survival in colorectal cancer

David Horst, Lydia Kriegl, J. Engel et al. · British Journal of Cancer · 2008 · 312 citations · Full text

, , +17

Prognostic Significance of the Cancer Stem Cell Markers CD133, CD44, and CD166 in Colorectal Cancer

David Horst, Lydia Kriegl, Jutta Engel et al. · Cancer Investigation · 2009 · 217 citations

, , +17

A Genetic Progression Model of BrafV600E-Induced Intestinal Tumorigenesis Reveals Targets for Therapeutic Intervention

Roland Rad, Juan Cadiñanos, Lena Rad et al. · Cancer Cell · 2013 · 214 citations · Full text

, , +15

Ink4a/Arf and Oncogene-Induced Senescence Prevent Tumor Progression during Alternative Colorectal Tumorigenesis

Moritz Bennecke, Lydia Kriegl, Monther Bajbouj et al. · Cancer Cell · 2010 · 185 citations · Full text

, , +14

SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer

Jens Neumann, Fiorina Bahr, David Horst et al. · BMC Cancer · 2011 · 154 citations · Full text

, , +17

1–5 of 21